Medical Device User Fee Rates for Fiscal Year 2016, 46033-46039 [2015-18907]
Download as PDF
46033
Federal Register / Vol. 80, No. 148 / Monday, August 3, 2015 / Notices
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday, and
will be posted to the docket at https://
www.regulations.gov.
IV. Electronic Access
Persons with access to the Internet
may obtain the guidance at either https://
www.fda.gov/BiologicsBloodVaccines/
GuidanceComplianceRegulatory
Information/Guidances/default.htm or
https://www.regulations.gov.
Dated: July 29, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015–18956 Filed 7–31–15; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2015–N–0007]
Medical Device User Fee Rates for
Fiscal Year 2016
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing the
fee rates and payment procedures for
medical device user fees for fiscal year
(FY) 2016. The Federal Food, Drug, and
Cosmetic Act (the FD&C Act), as
amended by the Medical Device User
Fee Amendments of 2012 (MDUFA III),
authorizes FDA to collect user fees for
certain medical device submissions and
annual fees both for certain periodic
reports and for establishments subject to
registration. This notice establishes the
fee rates for FY 2016, which apply from
October 1, 2015, through September 30,
2016. To avoid delay in the review of
your application, you should pay the
application fee before or at the time you
submit your application to FDA. The fee
you must pay is the fee that is in effect
on the later of the date that your
application is received by FDA or the
date your fee payment is recognized by
the U.S. Treasury. If you want to pay a
reduced small business fee, you must
qualify as a small business before
making your submission to FDA; if you
do not qualify as a small business before
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
making your submission to FDA, you
will have to pay the higher standard fee.
Please note that the establishment
registration fee is not eligible for a
reduced small business fee. As a result,
if the establishment registration fee is
the only medical device user fee that
you will pay in FY 2016, you should not
submit a FY 2016 Small Business
Qualification and Certification request.
This document provides information on
how the fees for FY 2016 were
determined, the payment procedures
you should follow, and how you may
qualify for reduced small business fees.
FOR FURTHER INFORMATION CONTACT: For
information on Medical Device User
Fees: Visit FDA’s Web site at https://
www.fda.gov/mdufa.
For questions relating to this notice:
David Miller, Office of Financial
Management, Food and Drug
Administration, 8455 Colesville Rd.
(COLE–14202E), Silver Spring, MD
20993–0002, 301–796–7103.
SUPPLEMENTARY INFORMATION:
I. Background
Section 738 of the FD&C Act (21
U.S.C. 379j) establishes fees for certain
medical device applications,
submissions, supplements, and notices
(for simplicity, this document refers to
these collectively as ‘‘submissions’’ or
‘‘applications’’); for periodic reporting
on class III devices; and for the
registration of certain establishments.
Under statutorily defined conditions, a
qualified applicant may receive a fee
waiver or may pay a lower small
business fee. (See 21 U.S.C. 379j(d) and
(e).) Additionally, the Secretary of
Health and Human Services (the
Secretary) may, at the Secretary’s sole
discretion, grant a fee waiver or
reduction if the Secretary finds that
such waiver or reduction is in the
interest of public health. (See 21 U.S.C.
379j(f).)
Under the FD&C Act, the fee rate for
each type of submission is set at a
specified percentage of the standard fee
for a premarket application (a premarket
application is a premarket approval
application (PMA), a product
development protocol (PDP), or a
biologics license application (BLA)).
The FD&C Act specifies the base fee for
a premarket application for each year
from FY 2013 through FY 2017; the base
fee for a premarket application received
by FDA during FY 2016 is $263,180.
From this starting point, this document
establishes FY 2016 fee rates for other
types of submissions, and for periodic
reporting, by applying criteria specified
in the FD&C Act.
The FD&C Act specifies the base fee
for establishment registration for each
year from FY 2013 through FY 2017; the
base fee for an establishment
registration in FY 2016 is $3,872. There
is no reduction in the registration fee for
small businesses. Each establishment
that is registered (or is required to
register) with the Secretary under
section 510 of the FD&C Act (21 U.S.C.
360) because such establishment is
engaged in the manufacture,
preparation, propagation, compounding,
or processing of a device is required to
pay the annual fee for establishment
registration.
II. Revenue Amount for FY 2016
The total revenue amount for FY 2016
is $129,339,949, as set forth in the
statute prior to the inflation adjustment.
(See 21 U.S.C. 379j(b)(3)(D)). MDUFA III
(Pub. L. 112–144) directs FDA to use the
yearly total revenue amount as a starting
point to set the standard fee rates for
each fee type. The fee calculations for
FY 2016 are described in this document.
Inflation Adjustment
MDUFA III specifies that the
$129,339,949 is to be adjusted for
inflation increases for FY 2016 using
two separate adjustments—one for
payroll costs and one for non-pay costs
(see 21 U.S.C. 379j(c)(2)). The base
inflation adjustment for FY 2016 is the
sum of one plus these two separate
adjustments, and is compounded as
specified (see 21 U.S.C. 379j(c)(2)(C)(1)
and 379j(c)(2)(B)(ii)).
The component of the inflation
adjustment for payroll costs is the
average annual percent change in the
cost of all personnel compensation and
benefits (PC&B) paid per full-time
equivalent position (FTE) at FDA for the
first 3 of the 4 preceding FYs,
multiplied by 0.60, or 60 percent (see 21
U.S.C. 379j(c)(2)(C)).
Table 1 summarizes the actual cost
and FTE data for the specified FYs, and
provides the percent change from the
previous FY and the average percent
change over the first 3 of the 4 FYs
preceding FY 2016. The 3-year average
is 2.2328 percent (rounded).
TABLE 1—FDA PC&BS EACH YEAR AND PERCENT CHANGE
Fiscal year
2012
Total PC&B ..............................................................................
Total FTE .................................................................................
VerDate Sep<11>2014
18:35 Jul 31, 2015
Jkt 235001
PO 00000
Frm 00102
$1,824,703,000
13,382
Fmt 4703
Sfmt 4703
2013
$1,927,703,000
13,974
E:\FR\FM\03AUN1.SGM
2014
$2,054,937,000
14,555
03AUN1
3-Year average
46034
Federal Register / Vol. 80, No. 148 / Monday, August 3, 2015 / Notices
TABLE 1—FDA PC&BS EACH YEAR AND PERCENT CHANGE—Continued
Fiscal year
2012
PC&B per FTE .........................................................................
Percent change from previous year ........................................
The payroll adjustment is 2.2328
percent multiplied by 60 percent, or
1.3397 percent.
The statute specifies that the
component of the inflation adjustment
for non-payroll costs for FY 2016 is the
average annual percent change that
occurred in the Consumer Price Index
(CPI) for urban consumers (Washington-
2013
$136,355
3.1843%
2014
$137,949
1.1690%
3-Year average
$141,184
2.3451%
2.2328%
Washington area. These data are
published by the Bureau of Labor
Statistics and can be found on their Web
site at https://data.bls.gov/cgi-bin/
surveymost?cu by checking the box
marked ‘‘Washington-Baltimore All
Items, November 1996=100—
CUURA311SA0’’ and then clicking on
the ‘‘Retrieve Data’’ button.
Baltimore, DC–MD–VA–WV; not
seasonally adjusted; all items; annual
index) for the first 3 of the preceding 4
years of available data multiplied by
0.40, or 40 percent (see 21 U.S.C.
379j(c)(2)(C)).
Table 2 provides the summary data
and the 3-year average percent change
in the specified CPI for the Baltimore-
TABLE 2—ANNUAL AND 3-YEAR AVERAGE PERCENT CHANGE IN BALTIMORE-WASHINGTON AREA CPI
Fiscal year
2012
2013
2014
Annual CPI ...............................................................................
Annual Percent Change ..........................................................
3-Yr Avg. Percent Change in CPI ...........................................
150.212
2.2024%
..............................
152.500
1.5232%
..............................
154.847
1.5390%
..............................
The non-pay adjustment is 1.7549
percent multiplied by 40 percent, or
0.7019 percent.
Next, the payroll adjustment (1.3397
percent or 0.013397) is added to the
non-pay adjustment (0.7019 percent or
0.007019), for a total of 2.0416 percent
(or 0.020416). To complete the inflation
adjustment, 1 (100 percent or 1.0) is
added for a total base inflation
adjustment of 1.020416 for FY 2016.
MDUFA III provides for this inflation
adjustment to be compounded for FY
2015 and each subsequent fiscal year
(see 21 U.S.C. 379j(c)(2)(B)(ii)). The base
3-Year average
1.7549%
III. Fees for FY 2016
inflation adjustment for FY 2016
(1.020416) is compounded by
multiplying it by the compounded
applicable inflation adjustment for FY
2015 (1.04316), as published in the
Federal Register of July 30, 2014 (79 FR
44178 to 44184), to reach the applicable
inflation adjustment of 1.064457
(rounded) (1.020416 times 1.04316) for
FY 2016. We then multiply the total
revenue amount for FY 2016
($129,339,949) by 1.064457, yielding an
inflation adjusted total revenue amount
of $137,677,000 (rounded to the nearest
thousand dollars).
Under the FD&C Act, all submission
fees and the periodic reporting fee are
set as a percent of the standard (full) fee
for a premarket application (see 21
U.S.C. 379j(a)(2)(A)). Table 3 provides
the last 3 years of fee paying submission
counts and the 3-year average. These
numbers are used to project the fee
paying submission counts that FDA will
receive in FY 2016. The fee paying
submission counts are published in the
MDUFA Financial Report to Congress
each year.
TABLE 3—3-YEAR AVERAGE OF FEE PAYING SUBMISSIONS
mstockstill on DSK4VPTVN1PROD with NOTICES
Application type
FY 2012
actual
Full Fee Applications ...............................................................
Small Business .................................................................
Panel-Track Supplement .........................................................
Small Business .................................................................
180-Day Supplements .............................................................
Small Business .................................................................
Real-Time Supplements ..........................................................
Small Business .................................................................
510(k)s .....................................................................................
Small Business .................................................................
30-Day Notice ..........................................................................
Small Business .................................................................
513(g) Request for Classification Information .........................
Small Business .................................................................
Annual Fee for Periodic Reporting 1 ........................................
Small Business 1 ...............................................................
Establishment Registration 2 ....................................................
25
6
12
0
145
21
196
22
2,865
1,086
801
60
46
30
478
39
..............................
1 Includes
FY 2013
actual
FY 2014
actual
23
9
19
0
128
21
182
23
3,149
1,202
956
69
65
38
614
54
23,477
25
5
12
3
122
24
192
19
3,034
1,037
934
91
69
31
514
56
24,026
3-Year
average
24
7
14
1
132
22
190
21
3,016
1,108
897
73
60
33
535
50
23,752
collection of quarter 4 billing for FY 2014 during FY 2015.
Registration total comes from the registration system and will vary from the financial report.
2 Establishment
The information in Table 3 is
necessary to estimate the amount of
VerDate Sep<11>2014
18:35 Jul 31, 2015
Jkt 235001
revenue that will be collected based on
the fee amounts. Table 4 displays both
PO 00000
Frm 00103
Fmt 4703
Sfmt 4703
the estimated revenue using the FY
2016 base fees set in statute and the
E:\FR\FM\03AUN1.SGM
03AUN1
Federal Register / Vol. 80, No. 148 / Monday, August 3, 2015 / Notices
estimated revenue after the inflation
adjustment to the FY 2016 base fees.
Using the fees set in statute and the 3year averages of fee paying submissions,
the collections would total
$138,620,884, which is $943,884 higher
than the statutory revenue limit.
Accordingly the PMA and establishment
fee need to be decreased so that
collections come as close to the
statutory revenue limit of $137,677,000
as possible without exceeding the limit.
This is done by calculating the
percentage difference between the
statutory revenue limit and the
estimated resulting 2016 revenue
collections, and then lowering the fees
proportionally by that percentage
46035
(rounded to the nearest dollar). After
recalculating the fees, a further $1
negative adjustment is made to the
establishment fee in order for the
estimated revenue to not exceed the
statutory limit. The fees in the second
column from the right are those we are
establishing in FY 2016, which are the
standard fees.
TABLE 4—FEES NEEDED TO ACHIEVE NEW FY 2016 REVENUE TARGET
FY 2016 Statutory
fees
(base fees)
Application type
Estimated
resulting 2016
revenue
Adjusted FY 2016
fees to meet
revenue target
(standard fees)
FY 2016 revenue
from adjusted fees
Full Fee Applications ...............................................................
Small Business .................................................................
Panel-Track Supplement .........................................................
Small Business .................................................................
180-Day Supplements .............................................................
Small Business .................................................................
Real-Time Supplements ..........................................................
Small Business .................................................................
510(k)s .....................................................................................
Small Business .................................................................
30-Day Notice ..........................................................................
Small Business .................................................................
513(g) Request for Classification Information .........................
Small Business .................................................................
Annual Fee for Periodic Reporting ..........................................
Small Business .................................................................
Establishment Registration ......................................................
$263,180
65,795
197,385
49,346
39,477
9,869
18,423
4,606
5,264
2,632
$4,211
2,106
3,553
1,777
9,211
2,303
3,872
$6,316,320
460,565
2,763,390
49,346
5,210,964
217,118
3,500,370
96,726
15,876,224
2,916,256
$3,777,267
153,738
213,180
58,641
4,927,885
115,150
91,967,744
$261,388
65,347
196,041
49,010
39,208
9,802
18,297
4,574
5,228
2,614
$4,182
2,091
3,529
1,765
9,149
2,287
3,845
$6,273,312
457,429
2,744,574
49,010
5,175,456
215,644
3,476,340
96,054
15,764,648
2,896,312
$3,751,254
152,643
211,740
58,245
4,894,715
114,350
91,326,440
Total ..................................................................................
..............................
138,620,884
..............................
137,661,256
The standard fee (adjusted base
amount) for a premarket application,
including a BLA, and for a premarket
report and a BLA efficacy supplement,
is $261,388 for FY 2016. The fees set by
reference to the standard fee for a
premarket application are:
• For a panel-track supplement, 75
percent of the standard fee;
• for a 180-day supplement, 15
percent of the standard fee;
• for a real-time supplement, 7
percent of the standard fee;
• for a 510(k) premarket notification,
2 percent of the standard fee;
• for a 30-day notice, 1.6 percent of
the standard fee;
• for a 513(g) (21 U.S.C. 360c(g))
request for classification information,
1.35 percent of the standard fee; and
• for an annual fee for periodic
reporting concerning a class III device,
3.5 percent of the standard fee.
For all submissions other than a
510(k) premarket notification, a 30-day
notice, and a 513(g) request for
classification information, the small
business fee is 25 percent of the
standard (full) fee for the submission.
(See 21 U.S.C. 379j(d)(2)(C).) For a
510(k) premarket notification
submission, a 30-day notice, and a
513(g) request for classification
information, the small business fee is 50
percent of the standard (full) fee for the
submission. (See 21 U.S.C. 379j(d)(2)(C)
and (e)(2)(C).)
The annual fee for establishment
registration, after adjustment, is set at
$3,845 for FY 2016. There is no small
business rate for the annual
establishment registration fee; all
establishments pay the same fee.
Table 5 summarizes the FY 2016 rates
for all medical device fees.
TABLE 5—MEDICAL DEVICE FEES FOR FY 2016
Standard fee
(as a percent of the standard fee
for a premarket application)
mstockstill on DSK4VPTVN1PROD with NOTICES
Application fee type
Premarket application (a PMA submitted under section 515(c)(1) of
the FD&C Act (21 U.S.C. 360e(c)(1)), a PDP submitted under
section 515(f) of the FD&C Act (21 U.S.C. 360e(f)), or a BLA
submitted under section 351 of the Public Health Service Act
(the PHS Act) (42 U.S.C. 262)).
Premarket report (submitted under section 515(c)(2) of the FD&C
Act).
Efficacy supplement (to an approved BLA under section 351 of the
PHS Act).
Panel-track supplement .....................................................................
180-day supplement ..........................................................................
Real-time supplement ........................................................................
510(k) premarket notification submission ..........................................
VerDate Sep<11>2014
19:53 Jul 31, 2015
Jkt 235001
PO 00000
Frm 00104
FY 2016
Standard fee
FY 2016 Small
business fee
Base Fee Adjusted as Specified
in the Statute.
$261,388
$65,347
100 ..............................................
261,388
65,347
100 ..............................................
261,388
65,347
75 ................................................
15 ................................................
7 ..................................................
2 ..................................................
196,041
39,208
18,297
5,228
49,010
9,802
4,574
2,614
Fmt 4703
Sfmt 4703
E:\FR\FM\03AUN1.SGM
03AUN1
46036
Federal Register / Vol. 80, No. 148 / Monday, August 3, 2015 / Notices
TABLE 5—MEDICAL DEVICE FEES FOR FY 2016—Continued
Standard fee
(as a percent of the standard fee
for a premarket application)
Application fee type
30-day notice .....................................................................................
513(g) request for classification information .....................................
Annual Fee Type:
Annual fee for periodic reporting on a class III device ..............
Annual establishment registration fee (to be paid by the establishment engaged in the manufacture, preparation, propagation, compounding, or processing of a device, as defined by
21 U.S.C. 379i(13)).
IV. How To Qualify as a Small Business
for Purposes of Medical Device Fees
If your business has gross receipts or
sales of no more than $100 million for
the most recent tax year, you may
qualify for reduced small business fees.
If your business has gross sales or
receipts of no more than $30 million,
you may also qualify for a waiver of the
fee for your first premarket application
(PMA, PDP, or BLA) or premarket
report. You must include the gross
receipts or sales of all of your affiliates
along with your own gross receipts or
sales when determining whether you
meet the $100 million or $30 million
threshold. If you want to pay the small
business fee rate for a submission, or
you want to receive a waiver of the fee
for your first premarket application or
premarket report, you should submit the
materials showing you qualify as a small
business 60 days before you send your
submission to FDA. If you make a
submission before FDA finds that you
qualify as a small business, you must
pay the standard (full) fee for that
submission.
If your business qualified as a small
business for FY 2015, your status as a
small business will expire at the close
of business on September 30, 2015. You
must requalify for FY 2016 in order to
pay small business fees during FY 2016.
mstockstill on DSK4VPTVN1PROD with NOTICES
A. Domestic (U.S.) Small Business
If you are a domestic (U.S.) business,
and wish to qualify as a small business
for FY 2016, you must submit the
following to FDA:
1. A completed FY 2016 MDUFA
Small Business Qualification
Certification (Form FDA 3602). This
form is provided in FDA’s guidance
document, ‘‘FY 2016 Medical Device
User Fee Small Business Qualification
and Certification,’’ available on FDA’s
Web site at https://www.fda.gov/
MedicalDevices/
DeviceRegulationandGuidance/
GuidanceDocuments/default.htm.
2. A certified copy of your Federal
(U.S.) Income Tax Return for the most
VerDate Sep<11>2014
18:35 Jul 31, 2015
Jkt 235001
4,182
3,529
2,091
1,765
3.50 .............................................
Base Fee Adjusted as Specified
in the Statute.
9,149
3,845
2,287
3,845
B. Foreign Small Business
If you are a foreign business, and wish
to qualify as a small business for FY
2016, you must submit the following:
1. A completed FY 2016 MDUFA
Foreign Small Business Qualification
Certification (Form FDA 3602A). This
form is provided in FDA’s guidance
document, ‘‘FY 2016 Medical Device
Frm 00105
FY 2016 Small
business fee
1.60 .............................................
1.35 .............................................
recent tax year. The most recent tax year
will be 2015, except:
If you submit your FY 2016 MDUFA
Small Business Qualification before
April 15, 2016, and you have not yet
filed your return for 2015, you may use
tax year 2014.
If you submit your FY 2016 MDUFA
Small Business Qualification on or after
April 15, 2016, and have not yet filed
your 2015 return because you obtained
an extension, you may submit your most
recent return filed prior to the
extension.
3. For each of your affiliates, either:
• If the affiliate is a domestic (U.S.)
business, a certified copy of the
affiliate’s Federal (U.S.) Income Tax
Return for the most recent tax year, or
• if the affiliate is a foreign business
and cannot submit a Federal (U.S.)
Income Tax Return, a National Taxing
Authority Certification completed by,
and bearing the official seal of, the
National Taxing Authority of the
country in which the firm is
headquartered. The National Taxing
Authority is the foreign equivalent of
the U.S. Internal Revenue Service. This
certification must show the amount of
gross receipts or sales for the most
recent tax year, in both U.S. dollars and
the local currency of the country, the
exchange rate used in converting the
local currency to U.S. dollars, and the
dates of the gross receipts or sales
collected. The applicant must also
submit a statement signed by the head
of the applicant’s firm or by its chief
financial officer that the applicant has
submitted certifications for all of its
affiliates, identifying the name of each
affiliate, or that the applicant has no
affiliates.
PO 00000
FY 2016
Standard fee
Fmt 4703
Sfmt 4703
User Fee Small Business Qualification
and Certification,’’ available on FDA’s
Internet site at https://www.fda.gov/
MedicalDevices/
DeviceRegulationandGuidance/
GuidanceDocuments/default.htm.
2. A National Taxing Authority
Certification, completed by, and bearing
the official seal of, the National Taxing
Authority of the country in which the
firm is headquartered. This certification
must show the amount of gross receipts
or sales for the most recent tax year, in
both U.S. dollars and the local currency
of the country, the exchange rate used
in converting the local currency to U.S.
dollars, and the dates of the gross
receipts or sales collected.
3. For each of your affiliates, either:
• If the affiliate is a domestic (U.S.)
business, a certified copy of the
affiliate’s Federal (U.S.) Income Tax
Return for the most recent tax year
(2015 or later), or
• if the affiliate is a foreign business
and cannot submit a Federal (U.S.)
Income Tax Return, a National Taxing
Authority Certification completed by,
and bearing the official seal of, the
National Taxing Authority of the
country in which the firm is
headquartered. The National Taxing
Authority is the foreign equivalent of
the U.S. Internal Revenue Service. This
certification must show the amount of
gross receipts or sales for the most
recent tax year, in both U.S. dollars and
the local currency of the country, the
exchange rate used in converting the
local currency to U.S. dollars, and the
dates for the gross receipts or sales
collected. The applicant must also
submit a statement signed by the head
of the applicant’s firm or by its chief
financial officer that the applicant has
submitted certifications for all of its
affiliates, identifying the name of each
affiliate, or that the applicant has no
affiliates.
V. Procedures for Paying Application
Fees
If your application or submission is
subject to a fee and your payment is
E:\FR\FM\03AUN1.SGM
03AUN1
Federal Register / Vol. 80, No. 148 / Monday, August 3, 2015 / Notices
received by FDA between October 1,
2015, and September 30, 2016, you must
pay the fee in effect for FY 2016. The
later of the date that the application is
received in the reviewing center’s
document room or the date the U.S.
Treasury recognizes the payment
determines whether the fee rates for FY
2015 or FY 2016 apply. FDA must
receive the correct fee at the time that
an application is submitted, or the
application will not be accepted for
filing or review.
FDA requests that you follow the
steps below before submitting a medical
device application subject to a fee to
ensure that FDA links the fee with the
correct application. (Note: In no case
should the check for the fee be
submitted to FDA with the application.)
A. Secure a Payment Identification
Number (PIN) and Medical Device User
Fee Cover Sheet From FDA Before
Submitting Either the Application or the
Payment
Log into the User Fee System at:
https://userfees.fda.gov/OA_HTML/
mdufmaCAcdLogin.jsp. Complete the
Medical Device User Fee cover sheet. Be
sure you choose the correct application
submission date range. (Two choices
will be offered until October 1, 2015.
One choice is for applications and fees
that will be received on or before
September 30, 2015, which are subject
to FY 2015 fee rates. A second choice
is for applications and fees received on
or after October 1, 2015, which are
subject to FY 2016 fee rates.) After
completing data entry, print a copy of
the Medical Device User Fee cover sheet
and note the unique PIN located in the
upper right-hand corner of the printed
cover sheet.
mstockstill on DSK4VPTVN1PROD with NOTICES
B. Electronically Transmit a Copy of the
Printed Cover Sheet With the PIN
When you are satisfied that the data
on the cover sheet are accurate,
electronically transmit the data to FDA
according to instructions on the screen.
Applicants are required to set up a user
account and password to assure data
security in the creation and electronic
submission of cover sheets.
C. Submit Payment for the Completed
Medical Device User Fee Cover Sheet
1. If paying with credit card or
electronic check (Automated Clearing
House (ACH) also known as eCheck):
FDA has partnered with the U.S.
Department of the Treasury to utilize
Pay.gov, a Web-based payment system,
for online electronic payment. You may
make a payment via electronic check or
credit card after submitting your cover
sheet. To pay online, select the ‘‘Pay
VerDate Sep<11>2014
18:35 Jul 31, 2015
Jkt 235001
Now’’ button. Credit card transactions
for cover sheets cannot exceed
$49,999.99.
2. If paying with a paper check:
• All paper checks must be in U.S.
currency from a U.S. bank and made
payable to the Food and Drug
Administration. (If needed, FDA’s tax
identification number is 53–0196965.)
• Please write your application’s
unique PIN (from the upper right-hand
corner of your completed Medical
Device User Fee cover sheet) on your
check.
• Mail the paper check and a copy of
the completed cover sheet to: Food and
Drug Administration, P.O. Box 979033,
St. Louis, MO 63197–9000. (Please note
that this address is for payments of
application and annual report fees only
and is not to be used for payment of
annual establishment registration fees.)
If you prefer to send a check by a
courier, the courier may deliver the
check to: U.S. Bank, Attn: Government
Lockbox 979033, 1005 Convention
Plaza, St. Louis, MO 63101. (Note: This
address is for courier delivery only.
Contact U.S. Bank at 314–418–4013 if
you have any questions about courier
delivery.)
3. If paying with a wire transfer:
• Please include your application’s
unique PIN (from the upper right-hand
corner of your completed Medical
Device User Fee cover sheet) in your
wire transfer. Without the PIN, your
payment may not be applied to your
cover sheet and review of your
application may be delayed.
• The originating financial institution
may charge a wire transfer fee. Ask your
financial institution about the fee and
add it to your payment to ensure that
your cover sheet is fully paid.
Use the following account
information when sending a wire
transfer: New York Federal Reserve
Bank, U.S. Department of Treasury,
TREAS NYC, 33 Liberty St., New York,
NY 10045, Acct. No. 75060099, Routing
No. 021030004, SWIFT: FRNYUS33,
Beneficiary: FDA, 8455 Colesville Rd.,
Silver Spring, MD 20993–0002.
FDA records the official application
receipt date as the later of the following:
(1) The date the application was
received by FDA or (2) the date the U.S.
Treasury recognizes the payment. It is
helpful if the fee arrives at the bank at
least 1 day before the application arrives
at FDA.
D. Submit Your Application to FDA
With a Copy of the Completed Medical
Device User Fee Cover Sheet
Please submit your application and a
copy of the completed Medical Device
PO 00000
Frm 00106
Fmt 4703
Sfmt 4703
46037
User Fee cover sheet to one of the
following addresses:
1. Medical device applications should
be submitted to: Food and Drug
Administration, Center for Devices and
Radiological Health, Document Mail
Center, 10903 New Hampshire Ave.,
Building 66, Rm. 0609, Silver Spring,
MD 20993–0002.
2. Biologics license applications
should be sent to: Food and Drug
Administration, Center for Biologics
Evaluation and Research, Document
Control Center, 10903 New Hampshire
Ave, Building 71, Rm. G112, Silver
Spring, MD 20993–0002.
VI. Procedures for Paying the Annual
Fee for Periodic Reporting
You will be invoiced at the end of the
quarter in which your PMA Periodic
Report is due. Invoices will be sent
based on the details included on your
PMA file. You are responsible for
ensuring FDA has your current billing
information, and you may update your
contact information for the PMA by
submitting an amendment.
1. The preferred payment method is
online using electronic check
(Automated Clearing House (ACH) also
known as eCheck) or credit card
(Discover, VISA, MasterCard, American
Express). Secure electronic payments
can be submitted using the User Fees
Payment Portal at https://
userfees.fda.gov/pay. After searching for
and locating your invoice, click ‘‘Pay
Now’’ to be redirected to Pay.gov. Note
that electronic payment options are
based on the balance due. Payment by
credit card is available for balances that
do not exceed $49,999.99. If the balance
exceeds this amount, only the ACH
option is available. Payments must be
drawn on U.S bank accounts or made
with U.S. credit cards.
2. If paying with a paper check:
All paper checks must be in U.S.
currency from a U.S. bank and made
payable to the Food and Drug
Administration. (If needed, FDA’s tax
identification number is 53–0196965.)
• Please write your invoice number
on the check.
• Mail the paper check and a copy of
invoice to: Food and Drug
Administration, P.O. Box 979033, St.
Louis, MO 63197–9000.
(Please note that this address is for
payments of application and annual report
fees only and is not to be used for payment
of annual establishment registration fees.)
If you prefer to send a check by a
courier, the courier may deliver the
check to: U.S. Bank, Attn: Government
Lockbox 979033, 1005 Convention
Plaza, St. Louis, MO 63101.
E:\FR\FM\03AUN1.SGM
03AUN1
46038
Federal Register / Vol. 80, No. 148 / Monday, August 3, 2015 / Notices
(Note: This address is for courier delivery
only. Contact the U.S. Bank at 314–418–4013
if you have any questions about courier
delivery.)
3. If paying with a wire transfer:
• Please include your invoice number
in your wire transfer. Without the
invoice number, your payment may not
be applied and you may be referred to
collections.
• The originating financial institution
may charge a wire transfer fee. Ask your
financial institution about the fee and
add it to your payment to ensure that
your invoice is fully paid.
Use the following account
information when sending a wire
transfer: New York Federal Reserve
Bank, U.S. Department of the Treasury,
TREAS NYC, 33 Liberty St., New York,
NY 10045, Acct. No. 75060099, Routing
No. 021030004, SWIFT: FRNYUS33,
Beneficiary: FDA, 8455 Colesville Rd.,
Silver Spring, MD 20993–0002.
mstockstill on DSK4VPTVN1PROD with NOTICES
VII. Procedures for Paying Annual
Establishment Fees
To pay the annual establishment fee,
firms must access the Device Facility
User Fee (DFUF) Web site at https://
userfees.fda.gov/OA_HTML/furls.jsp.
(FDA has verified the Web site address,
but FDA is not responsible for any
subsequent changes to the Web site
address after this document publishes in
the Federal Register.) Create a DFUF
order and you will be issued a PIN
when you place your order. After
payment has been processed, you will
be issued a payment confirmation
number (PCN). You will not be able to
register your establishment if you do not
have a PIN and a PCN. An establishment
required to pay an annual establishment
registration fee is not legally registered
in FY 2016 until it has completed the
steps below to register and pay any
applicable fee. (See 21 U.S.C. 379j(g)(2).)
Companies that do not manufacture
any product other than a licensed
biologic are required to register in the
Blood Establishment Registration (BER)
system. FDA’s Center for Biologics
Evaluation and Research (CBER) will
send establishment registration fee
invoices annually to these companies.
A. Submit a DFUF Order With a PIN
From FDA Before Registering or
Submitting Payment
To submit a DFUF Order, you must
create or have previously created a user
account and password for the user fee
Web site listed previously in this
section. After creating a user name and
password, log into the Establishment
Registration User Fee FY 2016 store.
Complete the DFUF order by entering
the number of establishments you are
VerDate Sep<11>2014
18:35 Jul 31, 2015
Jkt 235001
registering that require payment. When
you are satisfied that the information in
the order is accurate, electronically
transmit the data to FDA according to
instructions on the screen. Print a copy
of the final DFUF order and note the
unique PIN located in the upper righthand corner of the printed order.
B. Pay For Your DFUF Order
Unless paying by credit card, all
payments must be in U.S. currency and
drawn on a U.S. bank.
1. If paying by credit card or
electronic check (ACH or eCheck):
The DFUF order will include payment
information, including details on how
you can pay online using a credit card
or electronic check. Follow the
instructions provided to make an
electronic payment.
2. If paying with a paper check:
You may pay by a check, in U.S.
dollars and drawn on a U.S. bank,
mailed to: Food and Drug
Administration, P.O. Box 979108, St.
Louis, MO 63197–9000. (Note: This
address is different from the address for
payments of application and annual
report fees and is to be used only for
payment of annual establishment
registration fees.)
If a check is sent by a courier that
requests a street address, the courier can
deliver the check to: U.S. Bank, Attn:
Government Lockbox 979108, 1005
Convention Plaza, St. Louis, MO 63101.
(Note: This U.S. Bank address is for
courier delivery only; do not send mail
to this address.)
Please make sure that both of the
following are written on your check: (1)
The FDA post office box number (P.O.
Box 979108) and (2) the PIN that is
printed on your order. Include a copy of
your printed order when you mail your
check.
3. If paying with a wire transfer:
Wire transfers may also be used to pay
annual establishment fees. To send a
wire transfer, please read and comply
with the following information:
Include your order’s unique PIN (in
the upper right-hand corner of your
completed DFUF order) in your wire
transfer. Without the PIN, your payment
may not be applied to your facility and
your registration may be delayed.
The originating financial institution
may charge a wire transfer fee. Ask your
financial institution about the fee and
add it to your payment to ensure that
your order is fully paid. Use the
following account information when
sending a wire transfer: New York
Federal Reserve Bank, U.S. Dept. of
Treasury, TREAS NYC, 33 Liberty St.,
New York, NY 10045, Acct. No.
75060099, Routing No. 021030004,
PO 00000
Frm 00107
Fmt 4703
Sfmt 4703
SWIFT: FRNYUS33, Beneficiary: FDA,
8455 Colesville Rd., Silver Spring, MD
20993–0002. (If needed, FDA’s tax
identification number is 53–0196965.)
C. Complete the Information Online To
Update Your Establishment’s Annual
Registration for FY 2016, or To Register
a New Establishment for FY 2016
Go to the Center for Devices and
Radiological Health’s Web site at https://
www.fda.gov/MedicalDevices/
DeviceRegulationandGuidance/
HowtoMarketYourDevice/
RegistrationandListing/default.htm and
click the ‘‘Access Electronic
Registration’’ link on the left side of the
page. This opens up a new page with
important information about the FDA
Unified Registration and Listing System
(FURLS). After reading this information,
click on the ‘‘Access Electronic
Registration’’ link in the middle of the
page. This link takes you to an FDA
Industry Systems page with tutorials
that demonstrate how to create a new
FURLS user account if your
establishment did not create an account
in FY 2015. Manufacturers of licensed
biologics should register in the BER
system at https://www.fda.gov/Biologics
BloodVaccines/GuidanceCompliance
RegulatoryInformation/Establishment
Registration/BloodEstablishment
Registration/default.htm.
Enter your existing account ID and
password to log into FURLS. From the
FURLS/FDA Industry Systems menu,
click on the Device Registration and
Listing Module (DRLM) of FURLS
button. New establishments will need to
register and existing establishments will
update their annual registration using
choices on the DRLM menu. When you
choose to register or update your annual
registration, the system will prompt you
through the entry of information about
your establishment and your devices. If
you have any problems with this
process, email: reglist@cdrh.fda.gov or
call 301–796–7400 for assistance. (Note:
This email address and telephone
number are for assistance with
establishment registration only; they are
not to be used for questions related to
other aspects of medical device user
fees.) Problems with BERS should be
directed to https://
www.accessdata.fda.gov/scripts/email/
cber/bldregcontact.cfm or call 240–402–
8360.
D. Enter Your DFUF Order PIN and PCN
After completing your annual or
initial registration and device listing,
you will be prompted to enter your
DFUF order PIN and PCN, when
applicable. This process does not apply
to establishments engaged only in the
E:\FR\FM\03AUN1.SGM
03AUN1
Federal Register / Vol. 80, No. 148 / Monday, August 3, 2015 / Notices
manufacture, preparation, propagation,
compounding, or processing of licensed
biologic devices. CBER will send
invoices for payment of the
establishment registration fee to such
establishments.
Dated: July 28, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015–18907 Filed 7–31–15; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
mstockstill on DSK4VPTVN1PROD with NOTICES
Advisory Committee on Heritable
Disorders in Newborns and Children;
Notice of Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463, codified at 5 U.S.C.
App.), notice is hereby given of the
following meeting:
Name: Advisory Committee on
Heritable Disorders in Newborns and
Children
Dates and Times: August 27, 2015, 9
a.m. to 5 p.m.
August 28, 2015, 10 a.m. to 1 p.m.
Place: Webinar and In-Person,
National Institutes of Health, 5635
Fishers Lane, Rockville, Maryland
20857
Status: The meeting will be open to
the public with attendance limited to
space availability. Participants also have
the option of viewing the meeting via
webinar. Whether attending in-person
or via webinar, all participants must
register for the meeting. Please register
at https://www.blsmeetings.net/
ACHDNCAugust2015. The registration
deadline is Friday, August 14, 2015,
11:59 p.m. Eastern Time.
Purpose: The Advisory Committee on
Heritable Disorders in Newborns and
Children (Committee), as authorized by
Public Health Service Act, Title XI,
§ 1111 (42 U.S.C. 300b-10), as amended
by the Newborn Screening Saves Lives
Reauthorization Act of 2014 (Pub. L.
113–240), was established to advise the
Secretary of the Department of Health
and Human Services about the
development of newborn screening
activities, technologies, policies,
guidelines, and programs for effectively
reducing morbidity and mortality in
newborns and children having, or at risk
for, heritable disorders. In addition, the
Committee’s recommendations
regarding additional conditions/
heritable disorders for screening that
have been adopted by the Secretary are
VerDate Sep<11>2014
18:35 Jul 31, 2015
Jkt 235001
included in the Recommended Uniform
Screening Panel (RUSP) and constitute
part of the comprehensive guidelines
supported by the Health Resources and
Services Administration. Pursuant to
section 2713 of the Public Health
Service Act, codified at 42 U.S.C.
300gg–13, non-grandfathered health
plans and group and individual health
insurance issuers are required to cover
evidence-informed care and screenings
included in the HRSA-supported
comprehensive guidelines without
charging a co-payment, co-insurance, or
deductible for plan years (in the
individual market, policy years)
beginning on or after the date that is one
year from the Secretary’s adoption of the
condition for screening.
Agenda: The meeting will include: (1)
A final evidence review report on the
Adrenoleukodystrophy (ALD) condition
nomination for inclusion in the RUSP;
(2) a presentation by the Newborn
Screening Technical Assistance and
Evaluation Program (NewSTEPs) on
their activities and the NewSTEPs data
repository, a centralized and secure
database designed for state newborn
screening programs to explore data to
meet program needs; (3) updates on the
implementation of screening for Severe
Combined Immunodeficiency, Critical
Congenital Heart Disease, and Pompe
Disease; and (4) updates from
workgroups focused on cost analysis in
newborn screening, newborn screening
timeliness, and pilot studies for
evidence-based reviews of conditions.
Following the final evidence review
report on ALD, the Committee also is
expected to vote on whether or not to
recommend to the Secretary the
addition of ALD to the RUSP. Agenda
items are subject to change as necessary
or appropriate. The agenda, webinar
information, Committee Roster, Charter,
presentations, and other meeting
materials will be located on the
Advisory Committee’s Web site at
https://www.hrsa.gov/
advisorycommittees/mchbadvisory/
heritabledisorders.
Public Comments: Members of the
public may present oral comments and/
or submit written comments. Comments
are part of the official Committee record.
The public comment period is
tentatively scheduled for both days of
the meeting. Advance registration is
required to present oral comments and/
or submit written comments. Please
register at https://www.blsmeetings.net/
ACHDNCAugust2015. The registration
deadline is Friday, August 14, 2015,
11:59 p.m. Eastern Time. Written
comments must be received by the
deadline in order to be included in the
August meeting briefing book. Written
PO 00000
Frm 00108
Fmt 4703
Sfmt 4703
46039
comments should identify the
individual’s name, address, email,
telephone number, professional or
business affiliation, type of expertise
(i.e., parent, researcher, clinician, public
health, etc.), and the topic/subject
matter of comments. To ensure that all
individuals who have registered to make
oral comments can be accommodated,
the allocated time may be limited.
Individuals who are associated with
groups or have similar interests may be
requested to combine their comments
and present them through a single
representative. No audiovisual
presentations are permitted. For
additional information or questions on
public comments, please contact Lisa
Vasquez, Maternal and Child Health
Bureau, Health Resources and Services
Administration; email: lvasquez@
hrsa.gov.
Contact Person: Anyone interested in
obtaining other relevant information
should contact Debi Sarkar, Maternal
and Child Health Bureau, Health
Resources and Services Administration,
Room 18W68, Parklawn Building, 5600
Fishers Lane, Rockville, Maryland
20857; email: dsarkar@hrsa.gov.More
information on the Advisory Committee
is available at https://www.hrsa.gov/
advisorycommittees/mchbadvisory/
heritabledisorders.
Jackie Painter,
Director, Division of the Executive Secretariat.
[FR Doc. 2015–18953 Filed 7–31–15; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: HIV Molecular Biology.
Date: August 7, 2015.
E:\FR\FM\03AUN1.SGM
03AUN1
Agencies
[Federal Register Volume 80, Number 148 (Monday, August 3, 2015)]
[Notices]
[Pages 46033-46039]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-18907]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2015-N-0007]
Medical Device User Fee Rates for Fiscal Year 2016
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing the fee
rates and payment procedures for medical device user fees for fiscal
year (FY) 2016. The Federal Food, Drug, and Cosmetic Act (the FD&C
Act), as amended by the Medical Device User Fee Amendments of 2012
(MDUFA III), authorizes FDA to collect user fees for certain medical
device submissions and annual fees both for certain periodic reports
and for establishments subject to registration. This notice establishes
the fee rates for FY 2016, which apply from October 1, 2015, through
September 30, 2016. To avoid delay in the review of your application,
you should pay the application fee before or at the time you submit
your application to FDA. The fee you must pay is the fee that is in
effect on the later of the date that your application is received by
FDA or the date your fee payment is recognized by the U.S. Treasury. If
you want to pay a reduced small business fee, you must qualify as a
small business before making your submission to FDA; if you do not
qualify as a small business before making your submission to FDA, you
will have to pay the higher standard fee. Please note that the
establishment registration fee is not eligible for a reduced small
business fee. As a result, if the establishment registration fee is the
only medical device user fee that you will pay in FY 2016, you should
not submit a FY 2016 Small Business Qualification and Certification
request. This document provides information on how the fees for FY 2016
were determined, the payment procedures you should follow, and how you
may qualify for reduced small business fees.
FOR FURTHER INFORMATION CONTACT: For information on Medical Device User
Fees: Visit FDA's Web site at https://www.fda.gov/mdufa.
For questions relating to this notice: David Miller, Office of
Financial Management, Food and Drug Administration, 8455 Colesville Rd.
(COLE-14202E), Silver Spring, MD 20993-0002, 301-796-7103.
SUPPLEMENTARY INFORMATION:
I. Background
Section 738 of the FD&C Act (21 U.S.C. 379j) establishes fees for
certain medical device applications, submissions, supplements, and
notices (for simplicity, this document refers to these collectively as
``submissions'' or ``applications''); for periodic reporting on class
III devices; and for the registration of certain establishments. Under
statutorily defined conditions, a qualified applicant may receive a fee
waiver or may pay a lower small business fee. (See 21 U.S.C. 379j(d)
and (e).) Additionally, the Secretary of Health and Human Services (the
Secretary) may, at the Secretary's sole discretion, grant a fee waiver
or reduction if the Secretary finds that such waiver or reduction is in
the interest of public health. (See 21 U.S.C. 379j(f).)
Under the FD&C Act, the fee rate for each type of submission is set
at a specified percentage of the standard fee for a premarket
application (a premarket application is a premarket approval
application (PMA), a product development protocol (PDP), or a biologics
license application (BLA)). The FD&C Act specifies the base fee for a
premarket application for each year from FY 2013 through FY 2017; the
base fee for a premarket application received by FDA during FY 2016 is
$263,180. From this starting point, this document establishes FY 2016
fee rates for other types of submissions, and for periodic reporting,
by applying criteria specified in the FD&C Act.
The FD&C Act specifies the base fee for establishment registration
for each year from FY 2013 through FY 2017; the base fee for an
establishment registration in FY 2016 is $3,872. There is no reduction
in the registration fee for small businesses. Each establishment that
is registered (or is required to register) with the Secretary under
section 510 of the FD&C Act (21 U.S.C. 360) because such establishment
is engaged in the manufacture, preparation, propagation, compounding,
or processing of a device is required to pay the annual fee for
establishment registration.
II. Revenue Amount for FY 2016
The total revenue amount for FY 2016 is $129,339,949, as set forth
in the statute prior to the inflation adjustment. (See 21 U.S.C.
379j(b)(3)(D)). MDUFA III (Pub. L. 112-144) directs FDA to use the
yearly total revenue amount as a starting point to set the standard fee
rates for each fee type. The fee calculations for FY 2016 are described
in this document.
Inflation Adjustment
MDUFA III specifies that the $129,339,949 is to be adjusted for
inflation increases for FY 2016 using two separate adjustments--one for
payroll costs and one for non-pay costs (see 21 U.S.C. 379j(c)(2)). The
base inflation adjustment for FY 2016 is the sum of one plus these two
separate adjustments, and is compounded as specified (see 21 U.S.C.
379j(c)(2)(C)(1) and 379j(c)(2)(B)(ii)).
The component of the inflation adjustment for payroll costs is the
average annual percent change in the cost of all personnel compensation
and benefits (PC&B) paid per full-time equivalent position (FTE) at FDA
for the first 3 of the 4 preceding FYs, multiplied by 0.60, or 60
percent (see 21 U.S.C. 379j(c)(2)(C)).
Table 1 summarizes the actual cost and FTE data for the specified
FYs, and provides the percent change from the previous FY and the
average percent change over the first 3 of the 4 FYs preceding FY 2016.
The 3-year average is 2.2328 percent (rounded).
Table 1--FDA PC&Bs Each Year and Percent Change
----------------------------------------------------------------------------------------------------------------
Fiscal year 2012 2013 2014 3-Year average
----------------------------------------------------------------------------------------------------------------
Total PC&B.......................... $1,824,703,000 $1,927,703,000 $2,054,937,000
Total FTE........................... 13,382 13,974 14,555
[[Page 46034]]
PC&B per FTE........................ $136,355 $137,949 $141,184
Percent change from previous year... 3.1843% 1.1690% 2.3451% 2.2328%
----------------------------------------------------------------------------------------------------------------
The payroll adjustment is 2.2328 percent multiplied by 60 percent,
or 1.3397 percent.
The statute specifies that the component of the inflation
adjustment for non-payroll costs for FY 2016 is the average annual
percent change that occurred in the Consumer Price Index (CPI) for
urban consumers (Washington-Baltimore, DC-MD-VA-WV; not seasonally
adjusted; all items; annual index) for the first 3 of the preceding 4
years of available data multiplied by 0.40, or 40 percent (see 21
U.S.C. 379j(c)(2)(C)).
Table 2 provides the summary data and the 3-year average percent
change in the specified CPI for the Baltimore-Washington area. These
data are published by the Bureau of Labor Statistics and can be found
on their Web site at https://data.bls.gov/cgi-bin/surveymost?cu by
checking the box marked ``Washington-Baltimore All Items, November
1996=100--CUURA311SA0'' and then clicking on the ``Retrieve Data''
button.
Table 2--Annual and 3-Year Average Percent Change in Baltimore-Washington Area CPI
----------------------------------------------------------------------------------------------------------------
Fiscal year 2012 2013 2014 3-Year average
----------------------------------------------------------------------------------------------------------------
Annual CPI.......................... 150.212 152.500 154.847
Annual Percent Change............... 2.2024% 1.5232% 1.5390%
3-Yr Avg. Percent Change in CPI..... ................. ................. ................. 1.7549%
----------------------------------------------------------------------------------------------------------------
The non-pay adjustment is 1.7549 percent multiplied by 40 percent,
or 0.7019 percent.
Next, the payroll adjustment (1.3397 percent or 0.013397) is added
to the non-pay adjustment (0.7019 percent or 0.007019), for a total of
2.0416 percent (or 0.020416). To complete the inflation adjustment, 1
(100 percent or 1.0) is added for a total base inflation adjustment of
1.020416 for FY 2016.
MDUFA III provides for this inflation adjustment to be compounded
for FY 2015 and each subsequent fiscal year (see 21 U.S.C.
379j(c)(2)(B)(ii)). The base inflation adjustment for FY 2016
(1.020416) is compounded by multiplying it by the compounded applicable
inflation adjustment for FY 2015 (1.04316), as published in the Federal
Register of July 30, 2014 (79 FR 44178 to 44184), to reach the
applicable inflation adjustment of 1.064457 (rounded) (1.020416 times
1.04316) for FY 2016. We then multiply the total revenue amount for FY
2016 ($129,339,949) by 1.064457, yielding an inflation adjusted total
revenue amount of $137,677,000 (rounded to the nearest thousand
dollars).
III. Fees for FY 2016
Under the FD&C Act, all submission fees and the periodic reporting
fee are set as a percent of the standard (full) fee for a premarket
application (see 21 U.S.C. 379j(a)(2)(A)). Table 3 provides the last 3
years of fee paying submission counts and the 3-year average. These
numbers are used to project the fee paying submission counts that FDA
will receive in FY 2016. The fee paying submission counts are published
in the MDUFA Financial Report to Congress each year.
Table 3--3-Year Average of Fee Paying Submissions
----------------------------------------------------------------------------------------------------------------
Application type FY 2012 actual FY 2013 actual FY 2014 actual 3-Year average
----------------------------------------------------------------------------------------------------------------
Full Fee Applications............... 25 23 25 24
Small Business.................. 6 9 5 7
Panel-Track Supplement.............. 12 19 12 14
Small Business.................. 0 0 3 1
180-Day Supplements................. 145 128 122 132
Small Business.................. 21 21 24 22
Real-Time Supplements............... 196 182 192 190
Small Business.................. 22 23 19 21
510(k)s............................. 2,865 3,149 3,034 3,016
Small Business.................. 1,086 1,202 1,037 1,108
30-Day Notice....................... 801 956 934 897
Small Business.................. 60 69 91 73
513(g) Request for Classification 46 65 69 60
Information........................
Small Business.................. 30 38 31 33
Annual Fee for Periodic Reporting 478 614 514 535
\1\................................
Small Business \1\.............. 39 54 56 50
Establishment Registration \2\...... ................. 23,477 24,026 23,752
----------------------------------------------------------------------------------------------------------------
\1\ Includes collection of quarter 4 billing for FY 2014 during FY 2015.
\2\ Establishment Registration total comes from the registration system and will vary from the financial report.
The information in Table 3 is necessary to estimate the amount of
revenue that will be collected based on the fee amounts. Table 4
displays both the estimated revenue using the FY 2016 base fees set in
statute and the
[[Page 46035]]
estimated revenue after the inflation adjustment to the FY 2016 base
fees. Using the fees set in statute and the 3-year averages of fee
paying submissions, the collections would total $138,620,884, which is
$943,884 higher than the statutory revenue limit. Accordingly the PMA
and establishment fee need to be decreased so that collections come as
close to the statutory revenue limit of $137,677,000 as possible
without exceeding the limit. This is done by calculating the percentage
difference between the statutory revenue limit and the estimated
resulting 2016 revenue collections, and then lowering the fees
proportionally by that percentage (rounded to the nearest dollar).
After recalculating the fees, a further $1 negative adjustment is made
to the establishment fee in order for the estimated revenue to not
exceed the statutory limit. The fees in the second column from the
right are those we are establishing in FY 2016, which are the standard
fees.
Table 4--Fees Needed To Achieve New FY 2016 Revenue Target
----------------------------------------------------------------------------------------------------------------
Adjusted FY 2016
FY 2016 Statutory Estimated fees to meet FY 2016 revenue
Application type fees (base fees) resulting 2016 revenue target from adjusted
revenue (standard fees) fees
----------------------------------------------------------------------------------------------------------------
Full Fee Applications............... $263,180 $6,316,320 $261,388 $6,273,312
Small Business.................. 65,795 460,565 65,347 457,429
Panel-Track Supplement.............. 197,385 2,763,390 196,041 2,744,574
Small Business.................. 49,346 49,346 49,010 49,010
180-Day Supplements................. 39,477 5,210,964 39,208 5,175,456
Small Business.................. 9,869 217,118 9,802 215,644
Real-Time Supplements............... 18,423 3,500,370 18,297 3,476,340
Small Business.................. 4,606 96,726 4,574 96,054
510(k)s............................. 5,264 15,876,224 5,228 15,764,648
Small Business.................. 2,632 2,916,256 2,614 2,896,312
30-Day Notice....................... $4,211 $3,777,267 $4,182 $3,751,254
Small Business.................. 2,106 153,738 2,091 152,643
513(g) Request for Classification 3,553 213,180 3,529 211,740
Information........................
Small Business.................. 1,777 58,641 1,765 58,245
Annual Fee for Periodic Reporting... 9,211 4,927,885 9,149 4,894,715
Small Business.................. 2,303 115,150 2,287 114,350
Establishment Registration.......... 3,872 91,967,744 3,845 91,326,440
---------------------------------------------------------------------------
Total........................... ................. 138,620,884 ................. 137,661,256
----------------------------------------------------------------------------------------------------------------
The standard fee (adjusted base amount) for a premarket
application, including a BLA, and for a premarket report and a BLA
efficacy supplement, is $261,388 for FY 2016. The fees set by reference
to the standard fee for a premarket application are:
For a panel-track supplement, 75 percent of the standard
fee;
for a 180-day supplement, 15 percent of the standard fee;
for a real-time supplement, 7 percent of the standard fee;
for a 510(k) premarket notification, 2 percent of the
standard fee;
for a 30-day notice, 1.6 percent of the standard fee;
for a 513(g) (21 U.S.C. 360c(g)) request for
classification information, 1.35 percent of the standard fee; and
for an annual fee for periodic reporting concerning a
class III device, 3.5 percent of the standard fee.
For all submissions other than a 510(k) premarket notification, a
30-day notice, and a 513(g) request for classification information, the
small business fee is 25 percent of the standard (full) fee for the
submission. (See 21 U.S.C. 379j(d)(2)(C).) For a 510(k) premarket
notification submission, a 30-day notice, and a 513(g) request for
classification information, the small business fee is 50 percent of the
standard (full) fee for the submission. (See 21 U.S.C. 379j(d)(2)(C)
and (e)(2)(C).)
The annual fee for establishment registration, after adjustment, is
set at $3,845 for FY 2016. There is no small business rate for the
annual establishment registration fee; all establishments pay the same
fee.
Table 5 summarizes the FY 2016 rates for all medical device fees.
Table 5--Medical Device Fees for FY 2016
----------------------------------------------------------------------------------------------------------------
Standard fee (as a percent of
Application fee type the standard fee for a FY 2016 Standard FY 2016 Small
premarket application) fee business fee
----------------------------------------------------------------------------------------------------------------
Premarket application (a PMA submitted Base Fee Adjusted as $261,388 $65,347
under section 515(c)(1) of the FD&C Act Specified in the Statute.
(21 U.S.C. 360e(c)(1)), a PDP submitted
under section 515(f) of the FD&C Act (21
U.S.C. 360e(f)), or a BLA submitted under
section 351 of the Public Health Service
Act (the PHS Act) (42 U.S.C. 262)).
Premarket report (submitted under section 100.......................... 261,388 65,347
515(c)(2) of the FD&C Act).
Efficacy supplement (to an approved BLA 100.......................... 261,388 65,347
under section 351 of the PHS Act).
Panel-track supplement..................... 75........................... 196,041 49,010
180-day supplement......................... 15........................... 39,208 9,802
Real-time supplement....................... 7............................ 18,297 4,574
510(k) premarket notification submission... 2............................ 5,228 2,614
[[Page 46036]]
30-day notice.............................. 1.60......................... 4,182 2,091
513(g) request for classification 1.35......................... 3,529 1,765
information.
Annual Fee Type:
Annual fee for periodic reporting on a 3.50......................... 9,149 2,287
class III device.
Annual establishment registration fee Base Fee Adjusted as 3,845 3,845
(to be paid by the establishment Specified in the Statute.
engaged in the manufacture,
preparation, propagation, compounding,
or processing of a device, as defined
by 21 U.S.C. 379i(13)).
----------------------------------------------------------------------------------------------------------------
IV. How To Qualify as a Small Business for Purposes of Medical Device
Fees
If your business has gross receipts or sales of no more than $100
million for the most recent tax year, you may qualify for reduced small
business fees. If your business has gross sales or receipts of no more
than $30 million, you may also qualify for a waiver of the fee for your
first premarket application (PMA, PDP, or BLA) or premarket report. You
must include the gross receipts or sales of all of your affiliates
along with your own gross receipts or sales when determining whether
you meet the $100 million or $30 million threshold. If you want to pay
the small business fee rate for a submission, or you want to receive a
waiver of the fee for your first premarket application or premarket
report, you should submit the materials showing you qualify as a small
business 60 days before you send your submission to FDA. If you make a
submission before FDA finds that you qualify as a small business, you
must pay the standard (full) fee for that submission.
If your business qualified as a small business for FY 2015, your
status as a small business will expire at the close of business on
September 30, 2015. You must requalify for FY 2016 in order to pay
small business fees during FY 2016.
A. Domestic (U.S.) Small Business
If you are a domestic (U.S.) business, and wish to qualify as a
small business for FY 2016, you must submit the following to FDA:
1. A completed FY 2016 MDUFA Small Business Qualification
Certification (Form FDA 3602). This form is provided in FDA's guidance
document, ``FY 2016 Medical Device User Fee Small Business
Qualification and Certification,'' available on FDA's Web site at
https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/default.htm.
2. A certified copy of your Federal (U.S.) Income Tax Return for
the most recent tax year. The most recent tax year will be 2015,
except:
If you submit your FY 2016 MDUFA Small Business Qualification
before April 15, 2016, and you have not yet filed your return for 2015,
you may use tax year 2014.
If you submit your FY 2016 MDUFA Small Business Qualification on or
after April 15, 2016, and have not yet filed your 2015 return because
you obtained an extension, you may submit your most recent return filed
prior to the extension.
3. For each of your affiliates, either:
If the affiliate is a domestic (U.S.) business, a
certified copy of the affiliate's Federal (U.S.) Income Tax Return for
the most recent tax year, or
if the affiliate is a foreign business and cannot submit a
Federal (U.S.) Income Tax Return, a National Taxing Authority
Certification completed by, and bearing the official seal of, the
National Taxing Authority of the country in which the firm is
headquartered. The National Taxing Authority is the foreign equivalent
of the U.S. Internal Revenue Service. This certification must show the
amount of gross receipts or sales for the most recent tax year, in both
U.S. dollars and the local currency of the country, the exchange rate
used in converting the local currency to U.S. dollars, and the dates of
the gross receipts or sales collected. The applicant must also submit a
statement signed by the head of the applicant's firm or by its chief
financial officer that the applicant has submitted certifications for
all of its affiliates, identifying the name of each affiliate, or that
the applicant has no affiliates.
B. Foreign Small Business
If you are a foreign business, and wish to qualify as a small
business for FY 2016, you must submit the following:
1. A completed FY 2016 MDUFA Foreign Small Business Qualification
Certification (Form FDA 3602A). This form is provided in FDA's guidance
document, ``FY 2016 Medical Device User Fee Small Business
Qualification and Certification,'' available on FDA's Internet site at
https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/default.htm.
2. A National Taxing Authority Certification, completed by, and
bearing the official seal of, the National Taxing Authority of the
country in which the firm is headquartered. This certification must
show the amount of gross receipts or sales for the most recent tax
year, in both U.S. dollars and the local currency of the country, the
exchange rate used in converting the local currency to U.S. dollars,
and the dates of the gross receipts or sales collected.
3. For each of your affiliates, either:
If the affiliate is a domestic (U.S.) business, a
certified copy of the affiliate's Federal (U.S.) Income Tax Return for
the most recent tax year (2015 or later), or
if the affiliate is a foreign business and cannot submit a
Federal (U.S.) Income Tax Return, a National Taxing Authority
Certification completed by, and bearing the official seal of, the
National Taxing Authority of the country in which the firm is
headquartered. The National Taxing Authority is the foreign equivalent
of the U.S. Internal Revenue Service. This certification must show the
amount of gross receipts or sales for the most recent tax year, in both
U.S. dollars and the local currency of the country, the exchange rate
used in converting the local currency to U.S. dollars, and the dates
for the gross receipts or sales collected. The applicant must also
submit a statement signed by the head of the applicant's firm or by its
chief financial officer that the applicant has submitted certifications
for all of its affiliates, identifying the name of each affiliate, or
that the applicant has no affiliates.
V. Procedures for Paying Application Fees
If your application or submission is subject to a fee and your
payment is
[[Page 46037]]
received by FDA between October 1, 2015, and September 30, 2016, you
must pay the fee in effect for FY 2016. The later of the date that the
application is received in the reviewing center's document room or the
date the U.S. Treasury recognizes the payment determines whether the
fee rates for FY 2015 or FY 2016 apply. FDA must receive the correct
fee at the time that an application is submitted, or the application
will not be accepted for filing or review.
FDA requests that you follow the steps below before submitting a
medical device application subject to a fee to ensure that FDA links
the fee with the correct application. (Note: In no case should the
check for the fee be submitted to FDA with the application.)
A. Secure a Payment Identification Number (PIN) and Medical Device User
Fee Cover Sheet From FDA Before Submitting Either the Application or
the Payment
Log into the User Fee System at: https://userfees.fda.gov/OA_HTML/mdufmaCAcdLogin.jsp. Complete the Medical Device User Fee cover sheet.
Be sure you choose the correct application submission date range. (Two
choices will be offered until October 1, 2015. One choice is for
applications and fees that will be received on or before September 30,
2015, which are subject to FY 2015 fee rates. A second choice is for
applications and fees received on or after October 1, 2015, which are
subject to FY 2016 fee rates.) After completing data entry, print a
copy of the Medical Device User Fee cover sheet and note the unique PIN
located in the upper right-hand corner of the printed cover sheet.
B. Electronically Transmit a Copy of the Printed Cover Sheet With the
PIN
When you are satisfied that the data on the cover sheet are
accurate, electronically transmit the data to FDA according to
instructions on the screen. Applicants are required to set up a user
account and password to assure data security in the creation and
electronic submission of cover sheets.
C. Submit Payment for the Completed Medical Device User Fee Cover Sheet
1. If paying with credit card or electronic check (Automated
Clearing House (ACH) also known as eCheck):
FDA has partnered with the U.S. Department of the Treasury to
utilize Pay.gov, a Web-based payment system, for online electronic
payment. You may make a payment via electronic check or credit card
after submitting your cover sheet. To pay online, select the ``Pay
Now'' button. Credit card transactions for cover sheets cannot exceed
$49,999.99.
2. If paying with a paper check:
All paper checks must be in U.S. currency from a U.S. bank
and made payable to the Food and Drug Administration. (If needed, FDA's
tax identification number is 53-0196965.)
Please write your application's unique PIN (from the upper
right-hand corner of your completed Medical Device User Fee cover
sheet) on your check.
Mail the paper check and a copy of the completed cover
sheet to: Food and Drug Administration, P.O. Box 979033, St. Louis, MO
63197-9000. (Please note that this address is for payments of
application and annual report fees only and is not to be used for
payment of annual establishment registration fees.)
If you prefer to send a check by a courier, the courier may deliver
the check to: U.S. Bank, Attn: Government Lockbox 979033, 1005
Convention Plaza, St. Louis, MO 63101. (Note: This address is for
courier delivery only. Contact U.S. Bank at 314-418-4013 if you have
any questions about courier delivery.)
3. If paying with a wire transfer:
Please include your application's unique PIN (from the
upper right-hand corner of your completed Medical Device User Fee cover
sheet) in your wire transfer. Without the PIN, your payment may not be
applied to your cover sheet and review of your application may be
delayed.
The originating financial institution may charge a wire
transfer fee. Ask your financial institution about the fee and add it
to your payment to ensure that your cover sheet is fully paid.
Use the following account information when sending a wire transfer:
New York Federal Reserve Bank, U.S. Department of Treasury, TREAS NYC,
33 Liberty St., New York, NY 10045, Acct. No. 75060099, Routing No.
021030004, SWIFT: FRNYUS33, Beneficiary: FDA, 8455 Colesville Rd.,
Silver Spring, MD 20993-0002.
FDA records the official application receipt date as the later of
the following: (1) The date the application was received by FDA or (2)
the date the U.S. Treasury recognizes the payment. It is helpful if the
fee arrives at the bank at least 1 day before the application arrives
at FDA.
D. Submit Your Application to FDA With a Copy of the Completed Medical
Device User Fee Cover Sheet
Please submit your application and a copy of the completed Medical
Device User Fee cover sheet to one of the following addresses:
1. Medical device applications should be submitted to: Food and
Drug Administration, Center for Devices and Radiological Health,
Document Mail Center, 10903 New Hampshire Ave., Building 66, Rm. 0609,
Silver Spring, MD 20993-0002.
2. Biologics license applications should be sent to: Food and Drug
Administration, Center for Biologics Evaluation and Research, Document
Control Center, 10903 New Hampshire Ave, Building 71, Rm. G112, Silver
Spring, MD 20993-0002.
VI. Procedures for Paying the Annual Fee for Periodic Reporting
You will be invoiced at the end of the quarter in which your PMA
Periodic Report is due. Invoices will be sent based on the details
included on your PMA file. You are responsible for ensuring FDA has
your current billing information, and you may update your contact
information for the PMA by submitting an amendment.
1. The preferred payment method is online using electronic check
(Automated Clearing House (ACH) also known as eCheck) or credit card
(Discover, VISA, MasterCard, American Express). Secure electronic
payments can be submitted using the User Fees Payment Portal at https://userfees.fda.gov/pay. After searching for and locating your invoice,
click ``Pay Now'' to be redirected to Pay.gov. Note that electronic
payment options are based on the balance due. Payment by credit card is
available for balances that do not exceed $49,999.99. If the balance
exceeds this amount, only the ACH option is available. Payments must be
drawn on U.S bank accounts or made with U.S. credit cards.
2. If paying with a paper check:
All paper checks must be in U.S. currency from a U.S. bank and made
payable to the Food and Drug Administration. (If needed, FDA's tax
identification number is 53-0196965.)
Please write your invoice number on the check.
Mail the paper check and a copy of invoice to: Food and
Drug Administration, P.O. Box 979033, St. Louis, MO 63197-9000.
(Please note that this address is for payments of application
and annual report fees only and is not to be used for payment of
annual establishment registration fees.)
If you prefer to send a check by a courier, the courier may deliver
the check to: U.S. Bank, Attn: Government Lockbox 979033, 1005
Convention Plaza, St. Louis, MO 63101.
[[Page 46038]]
(Note: This address is for courier delivery only. Contact the
U.S. Bank at 314-418-4013 if you have any questions about courier
delivery.)
3. If paying with a wire transfer:
Please include your invoice number in your wire transfer.
Without the invoice number, your payment may not be applied and you may
be referred to collections.
The originating financial institution may charge a wire
transfer fee. Ask your financial institution about the fee and add it
to your payment to ensure that your invoice is fully paid.
Use the following account information when sending a wire transfer:
New York Federal Reserve Bank, U.S. Department of the Treasury, TREAS
NYC, 33 Liberty St., New York, NY 10045, Acct. No. 75060099, Routing
No. 021030004, SWIFT: FRNYUS33, Beneficiary: FDA, 8455 Colesville Rd.,
Silver Spring, MD 20993-0002.
VII. Procedures for Paying Annual Establishment Fees
To pay the annual establishment fee, firms must access the Device
Facility User Fee (DFUF) Web site at https://userfees.fda.gov/OA_HTML/furls.jsp. (FDA has verified the Web site address, but FDA is not
responsible for any subsequent changes to the Web site address after
this document publishes in the Federal Register.) Create a DFUF order
and you will be issued a PIN when you place your order. After payment
has been processed, you will be issued a payment confirmation number
(PCN). You will not be able to register your establishment if you do
not have a PIN and a PCN. An establishment required to pay an annual
establishment registration fee is not legally registered in FY 2016
until it has completed the steps below to register and pay any
applicable fee. (See 21 U.S.C. 379j(g)(2).)
Companies that do not manufacture any product other than a licensed
biologic are required to register in the Blood Establishment
Registration (BER) system. FDA's Center for Biologics Evaluation and
Research (CBER) will send establishment registration fee invoices
annually to these companies.
A. Submit a DFUF Order With a PIN From FDA Before Registering or
Submitting Payment
To submit a DFUF Order, you must create or have previously created
a user account and password for the user fee Web site listed previously
in this section. After creating a user name and password, log into the
Establishment Registration User Fee FY 2016 store. Complete the DFUF
order by entering the number of establishments you are registering that
require payment. When you are satisfied that the information in the
order is accurate, electronically transmit the data to FDA according to
instructions on the screen. Print a copy of the final DFUF order and
note the unique PIN located in the upper right-hand corner of the
printed order.
B. Pay For Your DFUF Order
Unless paying by credit card, all payments must be in U.S. currency
and drawn on a U.S. bank.
1. If paying by credit card or electronic check (ACH or eCheck):
The DFUF order will include payment information, including details
on how you can pay online using a credit card or electronic check.
Follow the instructions provided to make an electronic payment.
2. If paying with a paper check:
You may pay by a check, in U.S. dollars and drawn on a U.S. bank,
mailed to: Food and Drug Administration, P.O. Box 979108, St. Louis, MO
63197-9000. (Note: This address is different from the address for
payments of application and annual report fees and is to be used only
for payment of annual establishment registration fees.)
If a check is sent by a courier that requests a street address, the
courier can deliver the check to: U.S. Bank, Attn: Government Lockbox
979108, 1005 Convention Plaza, St. Louis, MO 63101. (Note: This U.S.
Bank address is for courier delivery only; do not send mail to this
address.)
Please make sure that both of the following are written on your
check: (1) The FDA post office box number (P.O. Box 979108) and (2) the
PIN that is printed on your order. Include a copy of your printed order
when you mail your check.
3. If paying with a wire transfer:
Wire transfers may also be used to pay annual establishment fees.
To send a wire transfer, please read and comply with the following
information:
Include your order's unique PIN (in the upper right-hand corner of
your completed DFUF order) in your wire transfer. Without the PIN, your
payment may not be applied to your facility and your registration may
be delayed.
The originating financial institution may charge a wire transfer
fee. Ask your financial institution about the fee and add it to your
payment to ensure that your order is fully paid. Use the following
account information when sending a wire transfer: New York Federal
Reserve Bank, U.S. Dept. of Treasury, TREAS NYC, 33 Liberty St., New
York, NY 10045, Acct. No. 75060099, Routing No. 021030004, SWIFT:
FRNYUS33, Beneficiary: FDA, 8455 Colesville Rd., Silver Spring, MD
20993-0002. (If needed, FDA's tax identification number is 53-0196965.)
C. Complete the Information Online To Update Your Establishment's
Annual Registration for FY 2016, or To Register a New Establishment for
FY 2016
Go to the Center for Devices and Radiological Health's Web site at
https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HowtoMarketYourDevice/RegistrationandListing/default.htm and click the
``Access Electronic Registration'' link on the left side of the page.
This opens up a new page with important information about the FDA
Unified Registration and Listing System (FURLS). After reading this
information, click on the ``Access Electronic Registration'' link in
the middle of the page. This link takes you to an FDA Industry Systems
page with tutorials that demonstrate how to create a new FURLS user
account if your establishment did not create an account in FY 2015.
Manufacturers of licensed biologics should register in the BER system
at https://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/EstablishmentRegistration/BloodEstablishmentRegistration/default.htm.
Enter your existing account ID and password to log into FURLS. From
the FURLS/FDA Industry Systems menu, click on the Device Registration
and Listing Module (DRLM) of FURLS button. New establishments will need
to register and existing establishments will update their annual
registration using choices on the DRLM menu. When you choose to
register or update your annual registration, the system will prompt you
through the entry of information about your establishment and your
devices. If you have any problems with this process, email:
reglist@cdrh.fda.gov or call 301-796-7400 for assistance. (Note: This
email address and telephone number are for assistance with
establishment registration only; they are not to be used for questions
related to other aspects of medical device user fees.) Problems with
BERS should be directed to https://www.accessdata.fda.gov/scripts/email/cber/bldregcontact.cfm or call 240-402-8360.
D. Enter Your DFUF Order PIN and PCN
After completing your annual or initial registration and device
listing, you will be prompted to enter your DFUF order PIN and PCN,
when applicable. This process does not apply to establishments engaged
only in the
[[Page 46039]]
manufacture, preparation, propagation, compounding, or processing of
licensed biologic devices. CBER will send invoices for payment of the
establishment registration fee to such establishments.
Dated: July 28, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-18907 Filed 7-31-15; 8:45 am]
BILLING CODE 4164-01-P